News

Navrogen Announces Publication of NAV-001 Antibody-Drug Conjugate Development and Efficacy in Humoral Immunosuppressed Cancers

by

The publication in PLOS ONE shows that NAV-001 has robust single-dose efficacy against multiple mesothelin-expressing cancers and that tumor-produced Humoral Immunology-Oncology (HIO) factors negatively impact antibody drug internalization and efficacy. CHEYNEY, Pa., May 18, 2023 /PRNewswire/ — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announces today a publication describing … Read more

BUILT EXPANDS PROTEIN-PACKED LINEUP WITH NEW WAYS TO SNACK FOR ANY OCCASION

by

BUILT Bites, BUILT Balls & BUILT Krispy Offer a New Way to Get the Best-Tasting, High Quality Protein On-the-Go AMERICAN FORK, Utah, May 18, 2023 /PRNewswire/ — BUILT, the maker of the best-tasting, protein-packed snack offerings, announces today the launch of three new healthy indulgent product innovations – BUILT Bites, BUILT Balls and BUILT Krispy. … Read more

Primrose Schools® Enters Midyear with Additions to C-Suite and 23 New Franchise Agreements Awarded

by

 Amidst continued investment in growth, early education and care leader honored with prestigious franchise industry awards ATLANTA, May 18, 2023 /PRNewswire/ — Primrose Schools, the premier early education and care leader with more than 480 franchised locations, kicked off 2023 with the opening of eight new locations and an incoming pipeline totaling 17 schools currently … Read more

Forum Health Doubles Texas Reach with Game-Changing 4 Location Acquisition

by

FLINT, Mich., May 18, 2023 /PRNewswire/ — Forum Health, LLC, the first nationwide network of integrative and functional medicine providers, has acquired Hormones by Design, one of the largest hormone replacement clinic networks in Texas.  Hormones by Design is a renowned healthcare provider specializing in hormone replacement therapy with four Texas locations in Waco, San … Read more

Skin Care Company The A Method® Launches Pro-Age Campaign

by

LOUISVILLE, Ken., May 18, 2023 /PRNewswire/ — The A Method® is a medical grade skincare line created by celebrity dermatologist Dr. Tina Alster and skincare formulation expert of over 25 years Angelia Inscoe. Together, they have taken a stance and shifted the brand’s “ethos” to a more “pro-age” message that encourages women to embrace beauty at any … Read more

eatCleaner® Fruit and Veggie Wash Receives EPA Safer Choice Label

by

eatCleaner® is the only patented and lab proven produce wash that removes up to 99.9% of unwanted residue including pesticides and has earned EPA’s Safer Choice label IRVINE, Calif., May 18, 2023 /PRNewswire/ — Grow Green Industries, Inc., the makers of eatCleaner® is proud to announce that our eatCleaner® Fruit and Veggie Wash products are … Read more

LA ROCHE-POSAY LAUNCHES NEW ANTHELIOS KIDS GENTLE LOTION SUNSCREEN SPF 50 WITH PEDIATRICIAN-TESTED FORMULA

by

NEW YORK, May 18, 2023 /PRNewswire/ — According to the Skin Cancer Foundation, just five sunburns before the age of 20 can double your risk of developing melanoma. Children are at a higher risk for UV-induced sun damage and are even more susceptible to sunburns than adults due to their more thin, sensitive skin, and … Read more

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

by

NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more

Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting

by

WALTHAM, Mass., May 18, 2023 /PRNewswire/ — Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for both rare and prevalent devastating diseases, today announced the presentation of new preclinical data on novel AAV capsids for skeletal muscle, cardiac muscle, and central nervous system (CNS). This research will be presented in an oral session today at 1:30pm PT … Read more

BridGene Biosciences to Present at Hippo Pathway Targeted Drug Development Summit

by

SAN JOSE, Calif., May 18, 2023 /PRNewswire/ — BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high-value, traditionally undruggable targets, announced that Wolf Wiedemeyer, Ph.D., head of biology at BridGene, will be giving a presentation, titled “A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & … Read more